Korea drug safety portal leak let ChatGPT retrieve 2,672 trial files, 1,195 people's data
South Korea's Korea Institute of Drug Safety & Risk Management (KIDS), part of the Ministry of Food and Drug Safety (MFDS), was found to have left backend server and file links on its drug safety portal accessible without login checks or passwords, allowing non-public material to be retrieved through ChatGPT. According to Yonhap, a lawmaker's office tested ChatGPT against the portal ahead of the October parliamentary audit and obtained 2,672 non-public clinical trial documents that manufacturers had submitted for approval, along with data on 1,195 people — names, mobile numbers and email addresses — described as clinical-trial reporting personnel. On October 14 KIDS posted a personal-data breach notice and apology on the portal, saying it had reviewed and fixed the security flaws, taken protective measures and reported the matter to the Personal Information Protection Commission.
The case shows that when a government site hides files only in the front end while leaving backend links unauthenticated, AI search tools can surface material that was never meant to be public.
圖片來源:
韓國食品藥物安全部(MFDS)
韓國食品藥物安全部(Ministry of Food and Drug Safety,MFDS)轄下機構上周被發現非公開臨床試驗資料可透過ChatGPT下載,為此道歉並著手調查。
韓國食品藥物安全部(MFDS)舊稱KFDA,角色等同於臺灣的衛福部食藥署(TFDA)或美國的FDA。
韓聯社報導,事件出於韓國一名議員辦公室在10月中韓國國政監察前夕,測試使用ChatGPT檢索藥品安全入口網站的相關資料。結果顯示,藥品安全入口網站雖然在前端網頁畫面上沒有將檔案公開顯示,但後端的伺服器與檔案連結對外部存取沒有設限,也沒有驗證登入權限或密碼,讓一般使用者可以用ChatGPT下提示查詢到原本不應該取得的資料。
這個漏洞讓ChatGPT順利查詢到製藥廠商送交韓國官方申請許可的非公開臨床試驗資料2,672份,此外還外洩1,195人的個資,包括名字、手機號碼和電子郵件信箱,受影響人士為臨床試驗相關報告人員。
10月14日,韓國食品藥物安全部轄下的韓國醫藥品安全管理院(Korea Institute of Drug Safety & Risk Management,KIDS)在藥品安全入口網站發布個資外洩公告並道歉,表示已檢查並改善網站安全漏洞,並採取必要的安全防護措施。同時,該單位已將此事通報個人資訊保護委員會。
#Ministry of Food and Drug Safety (MFDS)#Korea Institute of Drug Safety & Risk Management (KIDS)#ChatGPT#Personal Information Protection Commission (South Korea)